Volume 29, Issue 3 (Summer 2021)                   Avicenna J Nurs Midwifery Care 2021, 29(3): 171-180 | Back to browse issues page

Ethics code: IR.UMSHA.REC.1398.026

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mehrpooya M, Taher A, Golgiri A, Mohammadi Y, Ahmadimoghaddam D. Evaluation of the Drug Interactions Frequency and Their Related Factors in Hospitalized Patients of the Intensive Care Unit in the Hamadan Besat Hospital. Avicenna J Nurs Midwifery Care. 2021; 29 (3) :171-180
URL: http://nmj.umsha.ac.ir/article-1-2339-en.html
1- Associate Professor, Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
2- Assistant Professor, Department of Anesthesiology and Critical Care, Hamadan University of Medical Sciences, Hamadan, Iran
3- Student of General Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4- Associate Professor, Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
5- Assistant Professor, Department of Pharmacology & Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran , d.ahmadimoghadam@umsha.ac.ir
Abstract:   (481 Views)

Background and Objective: Drug interactions are one of the problems caused by the irrational administration of drugs and one of the common causes of morbidity and mortality in patients. Since drug interactions are usually predictable, they are therefore avoidable and manageable. This study aimed to evaluate the frequency of drug interactions and their related factors in hospitalized patients of the intensive care unit in the Hamadan Besat hospital, Iran.
Material and Methods: This cross-sectional study was performed on the clinical records of patients admitted to the intensive care unit (2019-2020) of Besat Hospital in Hamadan, Iran. Data were analyzed to determine the type of drug interactions based on the interactions available on the Up To Date and RxList databases. Other information was obtained from the patients' clinical records. Completion of information was recorded in the Pre-Design checklist. Finally, the data was analyzed using SPSS software version 22 and appropriate descriptive-analytical methods.
Results: The mean number of total drug interactions per prescription was 5.94 ± 4.91. Most interactions were type C (63.89%), Moderate (67.66%), Fair (70.96%) and Significant (44.76%).
Conclusion: According to the results, prolonged stay in an intensive care unit, the elderly, and polypharmacy are the main important factors associated with the occurrence of drug-drug interactions. These results indicate the importance of paying more attention to the monitoring and control of prescribed drugs in these patients.

Full-Text [PDF 1158 kb]   (27 Downloads)    

✅ According to the results, prolonged stay in an intensive care unit, the elderly, and polypharmacy are the main important factors associated with the occurrence of drug-drug interactions. These results indicate the importance of paying more attention to the monitoring and control of prescribed drugs in these patients.


Type of Study: Original Research | Subject: Nursing
Received: 2021/05/30 | Accepted: 2021/09/2 | Published: 2021/09/21

References
1. Stetina P, Groves M, Pafford L. Managing medication errors-a qualitative study. Med Surg Nurs. 2005;14(3):174.
2. Stratton KM, Blegen MA, Pepper G, Vaughn T. Reporting of medication errors by pediatric nurses. J Pediatr Nurs. 2004;19(6):385-92. [DOI:10.1016/j.pedn.2004.11.007] [PMID]
3. Hansen RA, Greene SB, Williams CE, Blalock SJ, Crook KD, Akers R, et al. Types of medication errors in North Carolina nursing homes: a target for quality improvement. Am J Geriatr Pharmacother. 2006;4(1):52-61. [DOI:10.1016/j.amjopharm.2006.03.007] [PMID]
4. Hughes RG, Ortiz E. Medication errors: why they happen, and how they can be prevented. J Infus Nurs. 2005;28:14-24. [DOI:10.1097/00000446-200503001-00005] [PMID]
5. Lehmann CU, Conner KG, Cox JM. Preventing provider errors: online total parenteral nutrition calculator. Pediatr. 2004;113(4):748-53. [DOI:10.1542/peds.113.4.748] [PMID]
6. Hammes JA, Pfuetzenreiter F, Silveira Fd, Koenig Á, Westphal GA. Potential drug interactions prevalence in intensive care units. Rev Bras Ter Intensiva. 2008;20(4):349-54. [DOI:10.1590/S0103-507X2008000400006] [PMID]
7. Baxter K, Preston CL. Stockley's drug interactions: Pharmaceutical Press London; 2010.
8. Fahimi F, Nazari MA, Abrishami R, Sistanizad M, Mazidi T, Faghihi T, et al. Transcription errors observed in a teaching hospital. Arch Iran Med (AIM). 2009;12(2).
9. Namazi S, Pourhatami S, Borhani-Haghighi A, Roosta S. Incidence of potential drug-drug interaction and related factors in hospitalized neurological patients in two Iranian teaching hospitals. Iran J Med Sci. 2014;39(6):515.
10. Rafiei H, Abdar ME, Amiri M, Ahmadinejad M. The study of harmful and beneficial drug interactions in intensive care, Kerman, Iran. J Intensive Care Soc. 2013;14(2):155-8. [DOI:10.1177/175114371301400214]
11. RAFI H, ARAB M, RANJBAR H, SEPEHRI G, ARAB N, AMIRI M. THE PREVALENCE OF POTENTIAL DRUG INTERACTIONS IN INTENSIVE CARES UNIT. Iran J Crit Care Nurs (IJCCN). 2012;4(4):-.
12. Janković SM, Pejčić AV, Milosavljević MN, Opančina VD, Pešić NV, Nedeljković TT, et al. Risk factors for potential drug-drug interactions in intensive care unit patients. J Crit care. 2018;43:1-6. [DOI:10.1016/j.jcrc.2017.08.021] [PMID]
13. Dai D, Feinstein JA, Morrison W, Zuppa AF, Feudtner C. Epidemiology of Polypharmacy and Potential Drug-Drug Interactions among Pediatric Patients in Intensive Care Units of US Children's Hospitals. Pediatric critical care medicine: J Soc Crit Care Med and World Fed Pediatr Intensive and Crit Care Soc. 2016;17(5):e218. [DOI:10.1097/PCC.0000000000000684] [PMID] [PMCID]
14. Rodrigues AT, Stahlschmidt R, Granja S, Falcao ALE, Moriel P, Mazzola PG. Clinical relevancy and risks of potential drug-drug interactions in intensive therapy. Saudi Pharm J. 2015;23(4):366-70. [DOI:10.1016/j.jsps.2014.11.014] [PMID] [PMCID]
15. Lima REF, Cassiani SHDB. Potential drug interactions in intensive care patients at a teaching hospital. Rev lat-Am Enfermag. 2009;17(2):222-7. [DOI:10.1590/S0104-11692009000200013] [PMID]
16. Brunton LL, Lazo JS, Parker KL. Goodman & Gilman's the pharmacological basis of therapeutics, McGraw-Hill, New York. USA. 2006.
17. Abideen S, VIVEKANANDAN K, MISHRA P. Assessment of prevalence of potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in India. ASSESSMENT. 2015;8(1).
18. Hosseini E, Shojaei L, Karimpour H, Shahbazi F. Potential Drug-Drug Interactions in Critically Ill Medical Patients: A Cross-Sectional Study. J Pharm Care. 2019;6(3-4):52-57.
19. Reis AMM, Cassiani SHDB. Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil. Clin. 2011;66(1):9-15. [DOI:10.1590/S1807-59322011000100003] [PMID] [PMCID]
20. Shakeel F, Khan JA, Aamir M, Asim SM, Ullah I. A multicentered pharmacoepidemiological approach to evaluate clinically significant potential drug-drug interactions in medical intensive care settings in Pakistan. Hong Kong J Emerg Med. 2018:1024907918765510. [DOI:10.1177/1024907918765510]
21. Smithburger PL, Kane‐Gill SL, Seybert AL. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. Int J Pharm Pract. 2012;20(6):402-8. [DOI:10.1111/j.2042-7174.2012.00221.x] [PMID]
22. Rafiei H, Esmaeili Abdar M, Moghadasi J. The prevalence of potential drug interactions among critically ill elderly patients in the intensive care unit (ICU). Iran J Ageing. 2012;6(4):14-9.
23. Rodrigues AT, Stahlschmidt R, Granja S, Pilger D, Falcão ALE, Mazzola PG. Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital. Braz J Pharm Sci. 2017;53(1). [DOI:10.1590/s2175-97902017000116109]
24. Alvim MM, Silva LAd, Leite ICG, Silvério MS. Adverse events caused by potential drug-drug interactions in an intensive care unit of a teaching hospital. Rev Bras Ter Intensiva. 2015;27(4):353-9. [DOI:10.5935/0103-507X.20150060] [PMID] [PMCID]
25. Rafati M, Nakhshab M, Irvash M, Rabiee T. Drug Interactions in Neonatal Intensive Critical Care Unit in Bu-Ali Sina Teaching Hospital, Sari, Iran. J Maz Univ Med Sci. 2016;25(133):305-9.
26. Vanham D, Spinewine A, Hantson P, Wittebole X, Wouters D, Sneyers B. Drug-drug interactions in the intensive care unit: Do they really matter? J Crit Care. 2017;38:97-103. [DOI:10.1016/j.jcrc.2016.09.014] [PMID]
27. Bhagavathula AS, Berhanie A, Tigistu H, Abraham Y, Getachew Y, Khan TM, et al. Prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia. Asian Pac J Trop Biomed. 2014;4:S204-S8. [DOI:10.12980/APJTB.4.2014C1172] [PMID] [PMCID]
28. Hajebi G, Mortazavi S. An Investigation of Drug Interactions in Hospital Pharmacy Prescriptions. Iran J Pharm Res. 2010;Volume 1(Number 1):15-9.
29. de Carvalho REFL, Reis AMM, de Faria LMP, de Azevedo Zago KS, Cassiani SHDB. Prevalence of drug interactions in intensive care units in Brazil. Acta Paul Enferm. 2013;26(2):150-7. [DOI:10.1590/S0103-21002013000200008]
30. Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58(11):773-8. [DOI:10.1007/s00228-002-0557-z] [PMID]
31. Moura C, Prado N, Acurcio F. Potential drug-drug interactions associated with prolonged stays in the intensive care unit. Clin Drug Investig. 2011;31(5):309-16. [DOI:10.1007/BF03256929] [PMID]
32. Ahmad A, Khan MU, Haque I, Ivan R, Dasari R, Revanker M, et al. Evaluation of potential drug-drug interactions in general medicine ward of teaching hospital in southern India. J Clin Diagnostic Res: JCDR. 2015;9(2):FC10. [DOI:10.7860/JCDR/2015/11264.5608] [PMID] [PMCID]
33. Raddad AR, Rashed AO, Bsharat A, Abu-Ghazaleh D, Yasin E, Shehab O. Evaluation of potential drug-drug interactions among Palestinian hemodialysis patients. BMC Nephrol. 2016;17(1):96. [DOI:10.1186/s12882-016-0317-4] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 CC BY-NC 4.0 | Avicenna Journal of Nursing and Midwifery Care

Designed & Developed by : Yektaweb